» Articles » PMID: 20937847

The Regulation of Th1 Responses by the P38 MAPK

Overview
Journal J Immunol
Date 2010 Oct 13
PMID 20937847
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

IL-12 is a dimeric cytokine that is produced primarily by APCs. In this study we examined the role that the p38 MAPKs (MAPK/p38) play in regulating IL-12 production. We show that inhibition of p38 dramatically increased IL-12 production upon stimulation, while decreasing TNF-α. This reciprocal effect on these two cytokines following MAPK/p38 inhibition occurred in many different APCs, following a variety of different stimuli. IL-12 production was also increased in macrophages treated with small interfering RNA to limit p38α expression, and in macrophages deficient in MKK3, a kinase upstream of p38. The increase in IL-12 production following MAPK/p38 inhibition appears to be due to enhanced IL-12 (p40) mRNA stability. We show that MAPK/p38 inhibition can promote Th1 immune responses and thereby enhance vaccine efficacy against leishmaniasis. In a mouse model of Leishmania major infection, vaccination with heat-killed L. major plus CpG and SB203580 elicited complete protection against infection compared with heat-killed L. major plus CpG without SB203580. Thus, this work suggests that MAPK/p38 inhibitors may be applied as adjuvants to bias immune responses and improve vaccinations against intracellular pathogens.

Citing Articles

Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling.

Chen C, Lin Y, Cheng L, Lin C, Ke G Vaccines (Basel). 2022; 10(5).

PMID: 35632471 PMC: 9145454. DOI: 10.3390/vaccines10050715.


Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated....

Dang W, Xiao J, Ma Q, Miao J, Cao M, Chen L Brain Tumor Pathol. 2021; 38(3):189-200.

PMID: 34231121 DOI: 10.1007/s10014-021-00404-3.


Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis.

Kaczanowska S, Beury D, Gopalan V, Tycko A, Qin H, Clements M Cell. 2021; 184(8):2033-2052.e21.

PMID: 33765443 PMC: 8344805. DOI: 10.1016/j.cell.2021.02.048.


MicroRNA-155 Suppresses the Translation of p38 and Impairs the Functioning of Dendritic Cells in Endometrial Cancer Mice.

Jia J, Li X, Guo S, Xie X Cancer Manag Res. 2020; 12:2993-3002.

PMID: 32431542 PMC: 7198441. DOI: 10.2147/CMAR.S240926.


CD28 CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection.

Bano A, Pera A, Almoukayed A, Clarke T, Kirmani S, Davies K F1000Res. 2019; 8.

PMID: 30984377 PMC: 6436193. DOI: 10.12688/f1000research.17119.1.


References
1.
Gaestel M, Mengel A, Bothe U, Asadullah K . Protein kinases as small molecule inhibitor targets in inflammation. Curr Med Chem. 2007; 14(21):2214-34. DOI: 10.2174/092986707781696636. View

2.
Dunn K, Espino P, Drobic B, He S, Davie J . The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol. 2005; 83(1):1-14. DOI: 10.1139/o04-121. View

3.
Gaestel M . MAPKAP kinases - MKs - two's company, three's a crowd. Nat Rev Mol Cell Biol. 2006; 7(2):120-30. DOI: 10.1038/nrm1834. View

4.
Rhee E, Mendez S, Shah J, Wu C, Kirman J, Turon T . Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection. J Exp Med. 2002; 195(12):1565-73. PMC: 2193566. DOI: 10.1084/jem.20020147. View

5.
Kang Y, Chen J, Otsuka M, Mols J, Ren S, Wang Y . Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation. J Immunol. 2008; 180(7):5075-82. DOI: 10.4049/jimmunol.180.7.5075. View